In a significant move, the Trump administration announced agreements with major drug manufacturers Eli Lilly and Novo Nordisk on November 6, 2025. These agreements aim to reduce the cost of popular ...

New research has discovered certain weight-loss medications could be associated with an increased risk of serious eye conditions, and even vision loss. Two studies, published in JAMA, analyzed how ...

The study, published in the journal Pharmacological Research, found that the drugs pemafibrate and telmisartan helped reduce ...

The Trump administration has negotiated lower prices for 15 widely used medications covered by Medicare, with the federal government saying the effort will cut spending on those drugs by 44%, or about ...

The idea of a “patent cliff” wave of exclusivity expirations shaking up the biopharma industry isn’t new: GEN first mentions the term in 2010 and again a year later when Lipitor (atorvastatin) lost ...

A case-control study revealed that combinations of drugs for cardiovascular diseases and hypertension were frequently prescribed before a diagnosis of bullous pemphigoid (BP), but the risk associated ...